Historical review from 2026-11-17. Current price and availability are unconfirmed; check the original marketplace.
Nose Job demonstrates meaningful traction at $3,081/mo revenue with exceptional 60% profit margins and an attractive 2.03x annual profit multiple. The verified financials and 11-month operating history provide concrete evidence of a working business model in a niche aesthetic-tech category. However, the relatively modest absolute revenue, lack of disclosed customer count or retention metrics, and absence of growth trajectory data warrant careful due diligence before acquisition to confirm sustainability and expansion potential.
The verified $22,176/year profit ($1,848/mo × 12) represents real, proven recurring revenue from a paying user base in a specialized niche. While the core AI face-morphing software could theoretically be built in 8–10 weeks using computer-vision APIs (like face.com, TensorFlow, or cloud ML services) at $8K–$15K in AI subscriptions and development, the acquisition captures an operational business with demonstrated product-market fit, an existing customer base, and 11 months of live-operation data. The buyer acquires immediate cash flow and market presence rather than rebuilding and re-acquiring users. At 2.03x annual profit, this represents fair value for a proven, bootstrapped AI business with real traction, assuming customer retention and unit economics are confirmed.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
AI face preview app for people considering facial aesthetic procedures. Users upload a selfie and see a realistic preview of rhinoplasty, eyelid, chin, lip, jawline and other facial changes on their o
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.